P-120 Interactions Between Thiopurine Metabolites and Adalimumab and Anti-adalimumab Antibodies in I...
P-120 Interactions Between Thiopurine Metabolites and Adalimumab and Anti-adalimumab Antibodies in Inflammatory Bowel Disease
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Interactions between cytotoxic thiopurine metabolites, 6-thioguanine nucleotides (6-TGN), and infliximab and anti-infliximab antibodies (Abs) have been related to superior effect of infliximab-thiopurine-combination therapy over monotherapy with either agent in inflammatory bowel disease (IBD).1 A recent randomized controlled trial did not indicate...
Alternative Titles
Full title
P-120 Interactions Between Thiopurine Metabolites and Adalimumab and Anti-adalimumab Antibodies in Inflammatory Bowel Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3169867427
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3169867427
Other Identifiers
ISSN
1078-0998
E-ISSN
1536-4844
DOI
10.1097/01.MIB.0000512639.23702.6f
